Please try another search
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Manuel Llobet | 57 | 2009 | CEO & Executive Director |
Peter Sinclair Jensen | 70 | 2010 | Independent Chairman |
Hendrik Kees Kam Nolte | - | - | Chairman of Scientific Advisory Board |
Lawrence M. Du Buske | - | - | Member of Scientific Advisory Board |
Anthony James Frew | - | - | Member of Scientific Advisory Board |
Johannes Ring | - | - | Member of Scientific Advisory Board |
Mary Geraldine Tavener | 62 | 2019 | Independent Non-Executive Director |
Babatunde Adekunle Otulana | 67 | 2017 | Senior Independent Director |
Cheryl Faye Macdiarmid | 55 | 2021 | Independent Non-Executive Director |
Zheqing Shen | 44 | 2022 | Non-Executive Director |
Anthony Michael Parker | 61 | 2022 | Non-Executive Director |
Shaun Antony Furlong | 48 | 2023 | CFO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review